Orbimed Advisors LLC Sarepta Therapeutics, Inc. Call Options Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $5.67 Million - $8.19 Million	50,000 New	50,000 $7.9 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $8.81 Million - $11.7 Million	75,000 New	75,000 $10.3 Million
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $4.76 Million - $5.68 Million	-100,000 Reduced 66.67%	50,000 $2.78 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $5.36 Million - $7.07 Million	150,000	150,000 $6.8 Million

530

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.